We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Correction: Updated safety results from phase 3 lecanemab study in early Alzheimer's disease.
- Authors
Honig, Lawrence S.; Sabbagh, Marwan N.; van Dyck, Christopher H.; Sperling, Reisa A.; Hersch, Steven; Matta, Andre; Giorgi, Luigi; Gee, Michelle; Kanekiyo, Michio; Li, David; Purcell, Derk; Dhadda, Shobha; Irizarry, Michael; Kramer, Lynn
- Abstract
This document is a correction notice for an article titled "Updated safety results from phase 3 lecanemab study in early Alzheimer's disease." The correction addresses typographical errors in the original article, including incorrect data in Table 2 and mislabeling of "ARIA-E" as "ARIA" in two places. The supplementary material has been updated to correct a participant's gender in Table S4. The document provides a table showing adverse events and ARIA in a clinical trial for lecanemab, as well as information on deaths in the study. The article has been updated, and the publisher remains neutral. The document also lists the names of several individuals mentioned by various authors.
- Subjects
ALZHEIMER'S disease; LECANEMAB
- Publication
Alzheimer's Research & Therapy, 2024, Vol 16, Issue 1, p1
- ISSN
1758-9193
- Publication type
Correction Notice
- DOI
10.1186/s13195-024-01507-7